Connect Biopharma Holdings Limited CNTB
Set alert
0.78 USD 0.00 -0.24%
As of Nov 3, 2:46 PM ET
0.7685 Day range 0.7949
0.732 52-week range 3.82
- YTD
- -72.51%
- 1 year
- -53.02%
- Open
- 0.78
- Prev close
- 0.7771
- Mkt cap
- 48.82M
- Vol
- 69.86K
- Avg vol
- 3.99M
- EPS
- -1.19
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.7685
- High
- 0.7949
- Forward P/E
- -5.04
- Beta
- -0.31
- Short ratio
- 1.93
- Inst. own
- 44.43%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 30, 2023
- 50-d avg
- 1.12
- 200-d avg
- 1.34
- 1y target
- 7.00
6M chart
Signals (36)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 5, 2026 | 4 weeks ago |
| RSI: Oversold | Sep 29, 2026 | 1 month ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 3, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
Newest 20 of 36.
Analyst view
Price target (mean) 7.00 +803.0% upside
Now 0.7752
- Target (low)
- 6.00
- Target (mean)
- 7.00
- Target (high)
- 8.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current year | -0.20 | -0.20 – -0.20 | -1.08 | +81.5% | 170.93M | 0.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -0.20 | +100.0% | 280.15M | +63.9% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 17, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 4, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Sep 13, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Feb 8, 2023 | SVB Leerink | Maintained | — | Outperform |
| Jun 2, 2022 | Cantor Fitzgerald | Initiated | — | Overweight |
| May 5, 2022 | Piper Sandler | Downgrade | Overweight | Neutral |
| May 4, 2022 | SVB Leerink | Maintained | — | Outperform |
| Jan 6, 2022 | SVB Leerink | Maintained | — | Outperform |
| Apr 13, 2021 | Jefferies | Initiated | — | Buy |
| Apr 13, 2021 | SVB Leerink | Initiated | — | Outperform |